April 21, 2015 Arno Therapeutics to Present Promising Data from Phase I Trial of Onapristone at AACR Annual Meeting 2015
April 13, 2015 Arno Therapeutics Announces Three Poster Presentations at Upcoming AACR Annual Meeting 2015
April 8, 2015 Capricor Completes Enrollment of Initial Phase of DYNAMIC Clinical Trial of Cardiosphere-Derived Cell Therapy for Treatment of Advanced Heart Failure
April 6, 2015 Kite Pharma Announces Publication in Science of Cancer Immunotherapy Articles Authored by Lead Collaborators at the National Cancer Institute and the Netherlands Cancer Institute
March 31, 2015 Capricor Therapeutics Completes Enrollment of Phase II Clinical Trial for Cenderitide to Treat Heart Failure
March 25, 2015 Kite Pharma to Report Fourth Quarter and Full Year 2014 Financial Results on March 26th, 2015
March 24, 2015 New Data Supporting Arno Therapeutics’ HDAC inhibitor AR-42 Published in The Journal of Urology
March 23, 2015 Capricor Therapeutics to Present at 3rd Annual Regen Med Investor Day on March 25, 2015 in New York
March 18, 2015 Capricor Therapeutics Reports Fourth Quarter and Full Year 2014 Financial & Business Highlights
March 17, 2015 Kite Pharma Strengthens Its T Cell Receptor (TCR) Cancer Gene Therapy Platform Through Acquisition of T-Cell Factory B.V. (TCF(TM))
March 12, 2015 Capricor Therapeutics to Hold Fourth Quarter 2014 Business Update Conference Call on March 18, 2015 at 4:30 p.m. EDT
March 5, 2015 Capricor Announces Enrollment of its Phase II Clinical Trial for Cenderitide to Treat Heart Failure
March 2, 2015 Kite Pharma Expands Its Research and Development Collaboration With the National Cancer Institute to Develop a Next Generation of Cancer Immunotherapy Products for Solid Tumors
February 19, 2015 Kite Pharma Establishes Manufacturing Capabilities to Support Development and Commercialization of CAR and TCR Cancer Immunotherapy Products
January 22, 2015 Kite Pharma Announces Expanded Agreement with Tel Aviv Sourasky Medical Center and Pioneering Researcher Professor Zelig Eshhar to Develop Novel Chimeric Antigen Receptor (CAR) Approaches for Cancer Immunotherapy
January 19, 2015 Kite Pharma Announces Presentations Highlighting Cancer Immunotherapy T Cell Manufacturing Process
